This Week in AGMs

This past and upcoming week in shareholder meetings - what happened, what to expect

This past week: if you missed it, catch last week’s TWAGM here

• Shareholder proposals at…

  • Stride (LRN): Report on Lobbying narrowly misses majority support: **49.5%**

    • See SEIU’s solicitation

    • Proposal:

      

  • Microsoft (MSFT): all results here

    • Report on Gender-Based Compensation and Benefit Gaps: 1.01%

    • Report on Risk from Omitting Ideology in EEO Policy: 0.81%

    • Report on Government Takedown Requests: 1.78%

    • Report on Risks of Weapons Development: 15.19%    

    • Report on Climate Risks to Retirement Plan Beneficiaries: 8.89%

    • Report on Tax Transparency: 21.25% 

    • Report on Data Operations in Human Rights Hotspots: 33.57%   

    • Mandate for Third-Party Political Reporting: 5.37%

    • Report on AI Misinformation and Disinformation: 21.16%

  • Cisco Systems (CSCO): Tax Transparency Report: 25.2%

• Low director election support at…

  • BILL Holdings (BILL): LID, Peter Kight (80.4%)

  • Madison Square Garden Entertainment (MSGE):

    • Martin Bandier (83.2%)

    • Donna M. Coleman (83.5%)

    • Frederic V. Salerno (83.5%)

      Consider that 64% of MSGE is owned by management and the board

      

  • eGain (EGAN): Nom Gov Chair, Gunjan Sinha (69.1%)

    • Consider that 34% of EGAN is owned by management and the board

      

  • Safety Shot (SHOT): Dr. Hector Alila FAILED to receive majority support (34.4%)

    • In good governance fashion, the board swiftly removed the director from the board (and added a new member rather quickly)

      The filing, however, appears to mistakenly mix up directors in the vote matrix, assigning Jarrett Boon the failed vote tabulation (rather than Alila)

      

  • Zymeworks (ZYME): Comp Chair, Hollings C. Renton (78%)

  • Bright Green (BGXX): all but one of the directors up for election received between 77-64%

  • Xenetic Biosciences (XBIO): Jeffrey Eisenberg (54.9%)

  • FG Group Holdings (FGH):

    • Audit Chair, William J. Gerber (75.7%)

    • Nom Gov Chair, Robert J. Roschman (76%)

    • Larry G. Swets, Jr. (81.3%)

  • SINTX (SINT):

    • Chair, CEO B. Sonny Bal, MD (62.6%)

    • Comp Committee Chair, Jeffrey S. White FAILED to receive majority support (41.9%) - ignored due to plurality vote standard

• Low compensation-related items at…

  • Cisco Systems (CSCO): Say-on-Pay (75%)

  • Zymeworks (ZYME): Say-on-Pay (74.7%)

  • Xenetic Biosciences (XBIO): FAILED Say-on-Pay (32.5%)

  • SINTX (SINT):

    • FAILED Say-on-Pay (44.6%)

    • FAILED Equity Incentive Plan (26.5%)

This upcoming week:

• Madison Square Garden Sports (MSGS): December 11

• WD-40 (WDFC): December 12

• RPT Realty (RPT): December 12

  • Vote on merger with Kimco Realty (KIM)

• Bowlero (BOWL): December 12

• Fabrinet (FN): December 12

• Palo Alto Networks (PANW): December 12

  • Company filed a supplemental deck disclosing that “Glass Lewis has recommended against votes for two of our directors; ISS and Glass Lewis have recommended votes against Proposal 3; and ISS has recommended a vote against Proposal 4”

    

    

    

• Stitch Fix (SFIX): December 12

• Mirati Therapeutics (MRTX): December 13

  • Voting on merger with Bristol-Myers Squibb (BMY)

  • “[I]n response to certain allegations,” the company filed supplemental disclosure here

• 1-800 Flowers.com (FLWS): December 13

• Aspen Technology (AZPN): December 14

• Comtech Telecommunications (CMTL): December 14

  • Company filed supplemental disclosure that mentioned ISS had recommended against their Say-on-Pay due to lack of responsiveness

    

• Riot Platforms (RIOT): December 14

• Factset Research Systems (FDS): December 14

• Winnebago Industries (WGO): December 14

• Jakks Pacific (JAKK): December 15

—

Drop me a line on LinkedIn, tell me what you think about the TWAGM series.

—

**Disclaimer**

The information provided in this blog/email is for general informational purposes only. While I strive to ensure the accuracy and reliability of the content, I make no representations or warranties of any kind, express or implied, about the completeness, accuracy, reliability, suitability, or availability with respect to the blog or the information, products, services, or related graphics contained on the blog for any purpose. Any reliance you place on such information is therefore strictly at your own risk. All posts and opinions expressed on this blog are solely my own and do not reflect the opinions or views of my employer. The content shared here is a representation of my personal thoughts and insights on various topics, and should not be considered as professional advice or the official stance of any organization. Please use your discretion and consult with relevant experts before making any decisions based on the information provided on this blog/in this email.